(S)-3-((S)-2-(5-(2-(Dimethylamino)Ethyl)-2 Oxo-4-(Trifluoromethyl)Pyridin-1(2H)-Yl)-4-Methylpentanamido)-3-(4-Fluoro-2',4',5,6'-Tetramethyl-[1,1'-Biphenyl]-3-Yl)Propanoic Acid

1 trials 1 recruiting

Filter these 1 trials by condition, phase, country and more.

Open in Search →

1 Registered trials

1 Recruiting

0 Completed trials

1 Sponsors

9 Countries

Phase II

Phase II: 1

Sponsors using this IMP

Eli Lilly & Co. 1

All trials

1 total

LY4268989 (MORF-057) Co-Administered with Mirikizumab in Adults with Moderately to Severely Active Ulcerative Colitis: A Phase 2 Study Recruiting

2025-522338-30-00 Phase II 9 countries Eli Lilly & Co.

Showing 1–1 of 1 trials

← All drugs A–Z